Apixaban News: Exemplary news revealed on July 1, 2013 that Apixaban, known as the brand name Eliquis, had achieved its primary goal in studies and proved to be an effective anticoagulant. Apixaban not only matched standard treatments for potentially fatal blood clots, but it was also deemed efficacious and safe. When compared to its competitor anticoagulant warfarin, Apixaban had a better safety profile, showing a 69 percent risk reduction for major bleeding events. Apixaban was initially approved on December 31, 2012 by the FDA to help reduce the risk of blood clots and stroke in patients who have atrial fibrillation that is not caused by a heart valve problem.
CSL Behring Receives FDA Approval of Kcentra(TM) for Urgent Warfarin Reversal in Patients with Acute Major BleedingEmployer News: PharmaDiversity Job Board is a Global Job Board featuring Companies with a commitment to diversity hiring all around...
Medscape FDA approves drug for urgent warfarin reversal Clinical Advisor HealthDay News -- The FDA has approved the first non-activated 4-factor prothrombin complex concentrate (Kcentra) to treat severe acute bleeding in adults after administration...
ESC issues "practical guide" to new oral anticoagulants in AF TheHeart.Org It covers four new oral anticoagulants: the direct thrombin inhibitor dabigatran (Pradaxa, Boehringer Ingelheim) and the factor Xa inhibitors rivaroxaban (Xarelto,...
The Food and Drug Administration has approved a new agent – Kcentra (Prothrombin Complex Concentrate, Human) – for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.